Department of Orthopedics, Clinical Orthopedic Research Center midden-Nederland (CORC-mN), Diakonessenhuis Hospital Utrecht/Zeist, PO Box 80250, 3508 TG, Utrecht, The Netherlands.
Department of Orthopedics, University Medical Center Utrecht, Heidelberglaan 100, 3508 GA, Utrecht, The Netherlands.
Arch Orthop Trauma Surg. 2023 Feb;143(2):829-838. doi: 10.1007/s00402-021-04190-7. Epub 2021 Sep 30.
Revisions for periprosthetic joint infection of knee and hip arthroplasty can be performed following one- or two-stage treatment protocols. Current literature is inconclusive whether one protocol is superior to the other, as prior literature reported similar reinfection rates for both treatment options. We aimed to provide a systematic review and meta-analysis of current literature on septic arthroplasty revisions.
Between April 2015 and December 2020, Medline, Embase, and The Cochrane Library were searched for studies reporting reinfection outcomes in patients treated with one-stage and two-stage knee or hip revision arthroplasty. Two reviewers independently extracted data and disagreements were resolved by a third investigator. We utilized a double arcsine transformation, prior to pooling using a random-effects model.
For hip revision arthroplasty, we identified 14 one-stage studies (n = 1237) with a pooled reinfection rate of 5.7% (95% CI 3.7-8.1%), and 46 two-stage studies (n = 5009) with a reinfection rate of 8.4% (95% CI 6.9-9.9%). For knee revision arthroplasty, 6 one-stage studies (n = 527) and 48 two-stage studies (n = 4344) were identified with reinfection rates of 12.7% (7.0-19.7%) and 16.2% (13.7-19.0%), respectively. Overall, reinfection rates did not vary substantially after subgroup analysis. Limitations of our study are the limited amount of one-stage studies that introduce a potential bias.
The reinfection rates following one- and two-stage hip and knee arthroplasty revisions were similar. Knee reinfection rates have increased compared to the previous analysis. Individual patient characteristics and adequate treatment algorithms are needed for a more individual selection approach, until a randomized trial is performed.
膝关节和髋关节置换术后假体周围关节感染的翻修可采用一期或二期治疗方案进行。目前的文献对于哪种方案更优尚无定论,因为之前的文献报告两种治疗选择的再感染率相似。我们旨在对当前关于感染性关节置换翻修的文献进行系统评价和荟萃分析。
在 2015 年 4 月至 2020 年 12 月期间,检索了 Medline、Embase 和 The Cochrane Library 中报道了一期和二期膝关节或髋关节翻修置换术患者再感染结果的研究。两位评审员独立提取数据,分歧由第三位评审员解决。我们使用双反正弦变换,然后使用随机效应模型进行汇总。
对于髋关节翻修术,我们确定了 14 项一期研究(n=1237),其再感染率为 5.7%(95%CI 3.7-8.1%),46 项二期研究(n=5009)的再感染率为 8.4%(95%CI 6.9-9.9%)。对于膝关节翻修术,我们确定了 6 项一期研究(n=527)和 48 项二期研究(n=4344),再感染率分别为 12.7%(7.0-19.7%)和 16.2%(13.7-19.0%)。总体而言,亚组分析后再感染率没有显著差异。本研究的局限性在于一期研究数量有限,这可能会引入潜在的偏倚。
一期和二期髋关节和膝关节置换术后翻修的再感染率相似。与之前的分析相比,膝关节再感染率有所增加。需要根据个体患者的特点和适当的治疗方案进行更个体化的选择方法,直到进行随机试验。